Organizations Filed Purposes:
TO INCREASE THE GENERAL BODY OF MEDICAL KNOWLEDGE REGARDING RHEUMATIC DISEASES (ARTHRITIS-RELATED ILLNESSES) BY PERFORMING RESEARCH USING THE DATA BANK AND PUBLISHING THAT RESEARCH IN PEER-REVIEWED MEDICAL JOURNALS. THE CLINICAL RESEARCH IS DESIGNED TO IMPROVE THE TREATMENT AND OUTCOMES OF THESE CONDITIONS.
RALLY BMS: TO EXAMINE THE SHORT-TERM AND LONG-TERM SAFETY AND EFFECTIVENESS OF ABATACEPT, DMARDS AND OTHER BIOLOGICS AS THEY ARE USED IN THE CLINICAL PRACTICE. A SECOND PURPOSE IS TO ASSESS THE LONG-TERM OUTCOMES OF THE 3 GROUPS OF PATIENTS WITH RESPECT TO FUNCTIONAL STATUS, WORK DISABILITY, MORTALITY, TOTAL JOINT REPLACEMENT, ADVERSE EVENTS, MEDICAL COSTS AND OTHER RA OUTCOMES. THIRD PURPOSE IS GENERAL SUPPORT OF THE NDB DATA BANK.
AMGEN STUDY: EXAMINE THE PREVALENCE OF SIDE EFFECTS REPORTED WITH METHOTREXATE COMPARED TO OTHER THERAPIES FOR PSA AND RA. EXAMINE TREATMENT BURDEN ASSOCIATED WITH THERAPIES FOR RA AND PSA.
UCB-CIMZIA: TO GAIN MORE INFORMATION ABOUT THE SAFETY OF CERTOLIZUMAB PEGO (CIMZIA) IN THE TREATMENT OF RA AND COMPARING CIMZIA SAFETY WITH THAT OF OTHER RA DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS).
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Kaleb Michaud Phd | DIRECTOR | 40 | $91,324 |
| Rebecca Schumacher | SECRETARY/TREASURER | 40 | $73,427 |
| Hyon Choi Md | DIRECTOR | 1 | $0 |
| James R O'Dell Md | DIRECTOR | 1 | $0 |
| Theodore Pincus Md | DIRECTOR | 1 | $0 |
| Donna Hawley Phd | DIRECTOR | 1 | $0 |
| Dr Frederick Wolfe Md | PRESIDENT | 40 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202012399349300001_public.xml